Business Context and Reporting Period
Company: CVS Corporation (CVS Health Corp)
Filing Type: Form 10-K (Annual Report)
Reporting Period: Fiscal year ended December 31, 2005 (52 weeks)
Business Overview: CVS is a leader in the U.S. retail drugstore industry, operating 5,471 retail and specialty pharmacy stores across 37 states and the District of Columbia. The company operates two primary segments: Retail Pharmacy (5,420 stores) and Pharmacy Benefit Management (PBM) via PharmaCare Management Services. In 2005, CVS filled over 433 million prescriptions, representing approximately 14% of the U.S. retail pharmacy market.
Key Financial Metrics
| Metric | 2005 (52 weeks) | 2004 (52 weeks) |
|---|---|---|
| Net Sales | $37,006.2 million | $30,594.3 million |
| Gross Margin | $9,901.2 million | $8,031.2 million |
| Operating Profit | $2,019.5 million | $1,454.7 million |
| Net Earnings | $1,224.7 million | $918.8 million |
| Diluted EPS | $1.45 | $1.10 |
| Total Assets | $15,283.4 million | $14,546.8 million |
| Long-term Debt | $1,594.1 million | $1,925.9 million |
| Total Shareholders' Equity | $8,331.2 million | $6,987.2 million |
Product Mix (2005): Prescription drugs accounted for 70% of net sales, followed by general merchandise and other (15%), over-the-counter and personal care (10%), and beauty/cosmetics (5%).
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 21% year-over-year, driven by store expansion and increased prescription volume.
- Profitability: Operating profit rose 39% to $2.02 billion, and net earnings increased 33% to $1.22 billion.
- Store Count: The company opened 166 new stores and relocated 131 stores in 2005, ending the year with 5,471 locations (up from 5,375 in 2004).
- Debt Reduction: Long-term debt decreased by approximately $332 million compared to 2004.
- Stock Split: A two-for-one stock split was effected in June 2005; all per-share data has been restated to reflect this.
Guidance, Outlook, Risks, and Unusual Items
Recent Developments and Outlook
- Acquisition: On January 22, 2006, CVS entered a definitive agreement to acquire approximately 700 standalone Sav-on and Osco drugstores and a distribution center from Albertson's for $2.93 billion in cash, plus $1.0 billion for real estate interests. Closing is expected in mid-2006.
- Store Development: The company expects to open approximately 250-275 new or relocated stores in 2006.
- Dividends: The Board authorized a 7% increase in the quarterly dividend to $0.03875 per share for Q1 2006.
Risks and Contingencies
- Regulatory Changes: The implementation of Medicare Part D (effective Jan 1, 2006) is expected to increase utilization but may decrease pharmacy gross margin rates as higher-margin cash/Medicaid customers migrate to the program. Additionally, the Deficit Reduction Act of 2005 is expected to reduce Medicaid reimbursement rates for generic drugs starting Jan 1, 2007.
- Legal Proceedings:
- SEC Inquiry: The SEC has commenced an informal inquiry regarding the accounting for a 2000 transaction involving plush toy inventory and barter credits. An internal review concluded certain accounting aspects were incorrect, though no financial statement adjustments were required. The Controller and Treasurer resigned in March 2006 following this review.
- Government Investigations: Ongoing investigations by the DOJ and state attorneys general regarding generic drug dispensing practices and a Rhode Island state investigation into business relationships with former legislators.
Investor Verification Checklist
- Acquisition Financing: Verify the final terms and financing structure for the $3.93 billion Albertson's drugstore acquisition.
- Medicare Part D Impact: Monitor Q1 and Q2 2006 results to assess the actual impact of Medicare Part D on gross margins and prescription volume.
- SEC Inquiry Resolution: Track the outcome of the SEC inquiry regarding the 2000 transaction and any potential restatements or penalties.
- Medicaid Reimbursement: Evaluate the company's strategy to negotiate higher dispensing fees with states to offset the 2007 Medicaid reimbursement cuts mandated by the Deficit Reduction Act.
- Executive Turnover: Monitor the appointment of a permanent Controller and Principal Accounting Officer following the March 2006 resignations.